142 related articles for article (PubMed ID: 37861550)
1. Role of TOP2A and CDC6 in liver cancer.
Jia W; Liu X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
[TBL] [Abstract][Full Text] [Related]
2. RRP9 and DDX21 as new biomarkers of colorectal cancer.
Chi X; Yang N; Liu Y
Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456
[TBL] [Abstract][Full Text] [Related]
3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
4. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
6. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
7. The high expression of TOP2A and MELK induces the occurrence of psoriasis.
Zhu X; Zhang E; Qin L
Aging (Albany NY); 2024 Feb; 16(4):3185-3199. PubMed ID: 38382096
[TBL] [Abstract][Full Text] [Related]
8. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.
Wu M; Liu Z; Zhang A; Li N
Medicine (Baltimore); 2019 Feb; 98(5):e14287. PubMed ID: 30702595
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
[TBL] [Abstract][Full Text] [Related]
10. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
13. KNTC1 and MCM2 are the molecular targets of gallbladder cancer.
Jia W; Wang C
Aging (Albany NY); 2023 Jul; 15(14):7008-7022. PubMed ID: 37480569
[TBL] [Abstract][Full Text] [Related]
14. CAV1 and KRT5 are potential targets for prostate cancer.
Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
[TBL] [Abstract][Full Text] [Related]
15. Construction of the miRNA-mRNA regulatory network and analysis of hub genes in oral squamous cell carcinoma.
Cui Z; Song Q; Chen Y; Yang K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):280-289. PubMed ID: 35132271
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
Zhuang L; Yang Z; Meng Z
Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
[TBL] [Abstract][Full Text] [Related]
17. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
18. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
19. Exploring Potential Biomarkers, Ferroptosis Mechanisms, and Therapeutic Targets Associated with Cutaneous Squamous Cell Carcinoma via Integrated Transcriptomic Analysis.
Su W; Huang B; Zhang Q; Han W; An L; Guan Y; Ji J; Yu D
J Healthc Eng; 2022; 2022():3524022. PubMed ID: 36247089
[TBL] [Abstract][Full Text] [Related]
20. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
